Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation

Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation

In the original publication of the article, the authors found few errors and the corrections are given below:

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer chemotherapy and pharmacology 2020, Vol.85 (1), p.237-239
Hauptverfasser: Yamaguchi, Ou, Kaira, Kyoichi, Mouri, Atsuto, Shiono, Ayako, Hashimoto, Kosuke, Miura, Yu, Nishihara, Fuyumi, Murayama, Yoshitake, Kobayashi, Kunihiko, Kagamu, Hiroshi
Format: Artikel
Sprache:eng
Schlagworte:
Cancer Research
Correction
Epidermal growth factor receptors
Lung cancer
Medicine
Medicine & Public Health
Mutation
Non-small cell lung carcinoma
Oncology
Pharmacology/Toxicology
Small cell lung carcinoma
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In the original publication of the article, the authors found few errors and the corrections are given below:
ISSN:0344-5704
1432-0843
DOI:10.1007/s00280-019-03984-2